DBV Technologies, VIASKIN Peanut Patch, Peanut Allergy, Food Allergy, Epicutaneous Immunotherapy, EPIT, BLA, FDA, Priority Review, Breakthrough Therapy, VITESSE, Phase 3,

CHÂTILLON, France — September 30, 2026 DBV Technologies announced the submission of a Biologics License Application (BLA) to the...